Filed before 2025Filed 27 April 2016
Gemphire Therapeutics Inc. has sold $10.6M so far
Gemphire Therapeutics Inc., a biotech company based in Northville, MI, has sold $10.6M so far in its debt round, according to a filing dated 27 April 2016.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 27 April 2016
- First filed
- 7 August 2015
- Round
- Debt round (amended filing)
- Amount sold
- $10.6M
- Offering size
- $14M
- Investors so far
- 59
- Based in
- Northville, MI
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 71% of the 1,506 tracked raises with an amount filed in 2016, and than 63% of the 120 in biotech.
Gemphire Therapeutics Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 27 Apr 2016 | Amended filing | $10.6M | This raise |
| 10 Mar 2016 | Amended filing | $5.6M | This raise |
| 22 Dec 2015 | Amended filing | $5.45M | This raise |
| 7 Aug 2015 | Amended filing | $2.8M | This raise |
| 7 Aug 2015 | New filing | $2.8M | This raise |
| 15 Apr 2015 | New filing | $5M | Another raise |
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.